Regulation of eNOS expression in HCAEC cell line treated with opioids and proinflammatory cytokines

Kardiologia Polska

Volumn 64, Issue 2, 2006, Pages 153-158

  Seidel, Monika ^a,c   Billert, Hanna ^b   Kurpisz, Maciej ^a,c  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Cardiovascular disease; eNOS; Opioids; Proinflammatory cytokines

Indexed keywords

BETA ENDORPHIN; CYTOKINE; ENDOMORPHIN 1; ENDOMORPHIN 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NALOXONE; OPIATE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1; NARCOTIC AGENT; NITRIC OXIDE SYNTHASE;

ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CORONARY ARTERY; DOWN REGULATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; ISCHEMIC PRECONDITIONING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; STIMULUS RESPONSE; STRESS; CARDIOVASCULAR DISEASE; CORONARY BLOOD VESSEL; ENZYMOLOGY; METABOLISM; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION;

CARDIOVASCULAR DISEASES; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1; NALOXONE; NARCOTICS; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746234675     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Takimoto Y, Aoyama T, Keyamura R, et al. Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat. Int J Cardiol 2000; 76 135-45.
2. Jones SP, Greer JJM, van Haperen R, et al. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. PNAS 2003; 100: 4891-6.
3. deFrutos T, deMiguel LS, Farre J, et al. Expression of an endothelial-type nitric oxide synthase isoform in human neutrophils: modification by tumor necrosis factor-alpha and during acute myocardial infarction. J Am Coll Cardiol 2001; 37: 800-7.
4. Gaballa MA, Goldman S. Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the hindlimb vasculature in ischemic heart failure in vivo. J Mol Cell Cardiol 1999; 31: 1243-52.
5. Deten A, Volz HC, Briest W, et al. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 2002; 55: 329-40.
6. Kraus J, Borner C, Giannini E, et al. The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 2003; 64: 876-84.
7. Horvath G.: Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous μ-opioid receptor agonists. Pharmacol Ther 2000; 88: 437-63.
8. ATP Channels. Circ Res 1999; 84: 846-51.
9. Balasubramanian S, Ramakrishnan S, Charboneau R, et al. Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol 2001; 33: 2179-87.
10. Fryer RM, Auchampach JA, Gross GJ. Therapeutic receptor targets of ischemic preconditioning. Cardiovasc Res 2002; 55: 520-5.
11. Patel HH, Moore J, Hsu AK, et al. Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism. J Mol Cell Cardiol 2002; 34: 1317-23.
12. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001; 89: 123-37.
13. Stefano GB, Goumon Y, Bilfinger TV, et al. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog Neurobiol 2000; 60: 513-30.
14. Mizoguchi H, Tseng LF, Suzuki T, et al. Recent advances in the search for the μ-opioidergic system; Differential mechanism of G-protein activation induced by endogenous μ-opioid peptides, endomorphin and β-endorphin. Jpn J Pharmacol 2002; 89: 229-34.
15. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002; 29: 23-39.
16. Agnoletti L, Curello S, Bachetti T, et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic. Circulation 1999; 100: 1983-91.